| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/10/2010 | CA2752648A1 Il-17 binding proteins |
| 09/09/2010 | US20100228007 Mhc-peptide complex binding ligands |
| 09/09/2010 | US20100227886 Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases |
| 09/09/2010 | US20100227885 Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases |
| 09/09/2010 | US20100227774 Method For Generating and Selecting Antibodies Against Target Protein |
| 09/09/2010 | US20100226995 Microencapsulated bioactive agents for oral delivery and methods of use thereof |
| 09/09/2010 | US20100226991 Solid inorganic/organic hybrid with modified surface |
| 09/09/2010 | US20100226985 Viscoelastic aqueous gels comprising microspheres |
| 09/09/2010 | US20100226975 Compositions and Methods for Stabilizing Lipid Based Adjuvant Formulations Using Glycolipids |
| 09/09/2010 | US20100226974 Antibody recognizing antigen |
| 09/09/2010 | US20100226973 Methods and compositions for liposomal formulation of antigens and uses thereof |
| 09/09/2010 | US20100226971 Ultrasound-enhanced intrascleral delivery of macromolecules |
| 09/09/2010 | US20100226967 Imaging and therapeutic method using progenitor cells |
| 09/09/2010 | US20100226965 Compositions & methods for wound healing |
| 09/09/2010 | US20100226953 Medical devices having a coating of biologic macromolecules |
| 09/09/2010 | US20100226942 Producing an immune response for reducing the risk of developing brucellosis |
| 09/09/2010 | US20100226941 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides |
| 09/09/2010 | US20100226940 Herpes simplex virus mutant icp0 |
| 09/09/2010 | US20100226939 Formulations for preservation of rotavirus |
| 09/09/2010 | US20100226938 Cellular and viral inactivation |
| 09/09/2010 | US20100226937 Combination vaccines with 1-hydroxy-2-phenoxyethane preservative |
| 09/09/2010 | US20100226934 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 09/09/2010 | US20100226933 Hypoallergenic proteins |
| 09/09/2010 | US20100226932 Adjuvant and Vaccine Compositions |
| 09/09/2010 | US20100226931 Compounds for immunopotentiation |
| 09/09/2010 | US20100226930 Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3 |
| 09/09/2010 | US20100226929 Direct Oxidation of Calcium/Calmodulin Dependent Protein Kinase II and Associated Diagnostic and Therapeutic Methods |
| 09/09/2010 | US20100226928 Lyophilised Antibody Formulation |
| 09/09/2010 | US20100226927 Selective immunodepletion of endogenous stem cell niche for engraftment |
| 09/09/2010 | US20100226926 Method of Detection of Fluorescence-Labeled Probes Attached to Diseased Solid Tissue |
| 09/09/2010 | US20100226925 Homogeneous Antibody Populations |
| 09/09/2010 | US20100226924 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 09/09/2010 | US20100226923 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/09/2010 | US20100226922 Specific protease inhibitors and their use in cancer therapy |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226920 Medical delivery device for therapeutic proteins based on single domain antibodies |
| 09/09/2010 | US20100226919 Antitumoral Treatments |
| 09/09/2010 | US20100226918 Pyrrole derivatives as p2y12 antagonists |
| 09/09/2010 | US20100226917 Methods for the treatment of hematologic malignancies |
| 09/09/2010 | US20100226916 Compositions and methods for treating ocular diseases and conditions |
| 09/09/2010 | US20100226915 AGER-Peptides and Use Thereof |
| 09/09/2010 | US20100226914 Method for preparation of single chain antibodies |
| 09/09/2010 | US20100226913 Therapeutic Compositions Comprising Monoterpenes |
| 09/09/2010 | US20100226912 RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLS |
| 09/09/2010 | US20100226911 Treating or preventing extracellular matrix build-up |
| 09/09/2010 | US20100226887 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis |
| 09/09/2010 | US20100226886 Combinations of MTP Inhibitors with Cholesterol Absorption Inhibitors or Interferon for Treating Hepatitis C |
| 09/09/2010 | US20100226884 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) |
| 09/09/2010 | US20100226883 Linked diimidazole derivatives |
| 09/09/2010 | US20100226882 Linked diimidazole antivirals |
| 09/09/2010 | US20100226880 Treatment with anti-vegf antibodies |
| 09/09/2010 | US20100226854 MHC Peptide Complexes and Uses Thereof in Infectious Diseases |
| 09/08/2010 | EP2226334A2 Immunoregulatory structures from normally occuring proteins |
| 09/08/2010 | EP2226081A1 Peptide vaccine using mimic molecule of amyloid beta-peptide |
| 09/08/2010 | EP2225389A1 Sm-protein based secretion engineering |
| 09/08/2010 | EP2225366A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 09/08/2010 | EP2225362A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 09/08/2010 | EP2225280A1 Bivalent, bispecific antibodies |
| 09/08/2010 | EP2225279A1 Bivalent, bispecific antibodies |
| 09/08/2010 | EP2225276A1 Antibodies to tnf alpha |
| 09/08/2010 | EP2225275A1 Protein formulation |
| 09/08/2010 | EP2225266A1 Novel wheat allergens |
| 09/08/2010 | EP2225265A2 Streptococcus pneumoniae vaccines |
| 09/08/2010 | EP2224956A1 Therapeutic targets and medicaments involving p230/golgin-245 |
| 09/08/2010 | EP2224955A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 09/08/2010 | EP2224954A2 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 09/08/2010 | EP2224953A1 Pharmaceutical formulation for allergen preparation |
| 09/08/2010 | EP2224951A1 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 09/08/2010 | EP1725258B1 Combination vaccines with low dose of hib conjugate |
| 09/08/2010 | EP1692183B1 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 09/08/2010 | EP1636254B1 Replikin peptides and uses thereof |
| 09/08/2010 | EP1610820B1 High concentration antibody and protein formulations |
| 09/08/2010 | EP1478667B1 Anti-human tenascin monoclonal antibody |
| 09/08/2010 | EP1476171B1 Transportation of nucleic acid substances |
| 09/08/2010 | EP1429797B1 Diagnosis and treatment of malignant neoplasms |
| 09/08/2010 | EP1377304B1 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 09/08/2010 | EP1328662B1 Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 09/08/2010 | EP1085905B1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 09/08/2010 | CN1942581B Antibody with osteoclast-related protein as target |
| 09/08/2010 | CN1754002B Compositions concerning poxviruses and cancer and its preparation method |
| 09/08/2010 | CN1750844B Use of lectin path specific CIq inhibitor for preparing pharmaceutical for preventing and treating tissue damage |
| 09/08/2010 | CN1566342B Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 09/08/2010 | CN101827863A Antibodies that bind IL-4 and/or IL-13 and their uses |
| 09/08/2010 | CN101827611A Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent |
| 09/08/2010 | CN101827610A Anti- MCP-1 antibodies, compositions, methods and uses |
| 09/08/2010 | CN101827609A High affinity human antibodies to human nerve growth factor |
| 09/08/2010 | CN101827608A Lyophilized immunoglobulin formulations and methods of preparation |
| 09/08/2010 | CN101827607A Influenza antigen delivery vectors and constructs |
| 09/08/2010 | CN101827606A RNA vaccines |
| 09/08/2010 | CN101827605A Mycoplasma bovis vaccine |
| 09/08/2010 | CN101827581A Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 09/08/2010 | CN101825638A Application of ADAM12m used as tumor marker and target molecule in diagnosing and treating tumors |
| 09/08/2010 | CN101824434A Antigen presenting cell, preparation method thereof and application thereof |
| 09/08/2010 | CN101824430A Double expression plasmid of hepatitis B virus, and construction method and application thereof |
| 09/08/2010 | CN101824424A DNA vaccine based on B7-2-PE40 exotoxin fusion gene and application thereof |
| 09/08/2010 | CN101824394A Streptococcus suis II-type subunit vaccine and application thereof |
| 09/08/2010 | CN101824393A Streptococcus suis II-type three-component subunit vaccine and application thereof |
| 09/08/2010 | CN101824090A Monoclonal antibody hpam4 |
| 09/08/2010 | CN101824088A Inhibition of il-17 production |
| 09/08/2010 | CN101824034A Imidazoquinoline compounds |